Navigation

Pulmonary embolism (acute treatment, VTE prevention) - rivaroxaban [ID569]

Treatment of acute symptomatic pulmonary embolism with or without symptomatic deep vein thrombosis and the prevention of recurrent venous thromboembolic events

Status: History
Expected date of issue: June 2013
Referral date: January 2011
Process: STA
Notes:

Scoped as part of Batch 15

Topic area:
  • Cardiovascular
 

NICE project team

Executive Lead: TBC
Technical Lead: Mary Hughes
Communications manager: Phil Ranson
Project manager: Bijal Joshi
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 16 January 2013
1st appraisal committee meeting: 05 March 2013
Top


 

Consultees and commentators

To be confirmed

Top


 

Key documents

This page was last updated: 02 July 2013

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.